These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 34265436)

  • 21. Assessment of Recovery Time, Worsening, and Death among Inpatients and Outpatients with COVID-19, Treated with Hydroxychloroquine or Chloroquine plus Azithromycin Combination in Burkina Faso.
    Rouamba T; Ouédraogo E; Barry H; Yaméogo NV; Sondo A; Boly R; Zoungrana J; Ouédraogo AR; Tahita MC; Poda A; Diendéré AE; Ouedraogo AS; Valea I; Traoré I; Tarnagda Z; Drabo MK; Tinto H;
    Int J Infect Dis; 2022 May; 118():224-229. PubMed ID: 35227869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical evidence for repurposing chloroquine and hydroxychloroquine as antiviral agents: a systematic review.
    Rodrigo C; Fernando SD; Rajapakse S
    Clin Microbiol Infect; 2020 Aug; 26(8):979-987. PubMed ID: 32470568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chloroquine and hydroxychloroquine for COVID-19: Perspectives on their failure in repurposing.
    Shah RR
    J Clin Pharm Ther; 2021 Feb; 46(1):17-27. PubMed ID: 32981089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydroxychloroquine and mortality in COVID-19 patients: a systematic review and a meta-analysis of observational studies and randomized controlled trials.
    Di Castelnuovo A; Costanzo S; Cassone A; Cauda R; De Gaetano G; Iacoviello L
    Pathog Glob Health; 2021; 115(7-8):456-466. PubMed ID: 34128772
    [No Abstract]   [Full Text] [Related]  

  • 25. Efficacy and safety of chloroquine and hydroxychloroquine for treatment of COVID-19 patients-a systematic review and meta-analysis of randomized controlled trials.
    Eze P; Mezue KN; Nduka CU; Obianyo I; Egbuche O
    Am J Cardiovasc Dis; 2021; 11(1):93-107. PubMed ID: 33815925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of hydroxychloroquine and chloroquine in patients with COVID-19: a meta-analysis of randomized clinical trials.
    Bignardi PR; Vengrus CS; Aquino BM; Cerci Neto A
    Pathog Glob Health; 2021 May; 115(3):139-150. PubMed ID: 33573530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Outcome of Hydroxychloroquine in Patients Treated for COVID-19: Systematic Review and Meta-Analysis.
    Ayele Mega T; Feyissa TM; Dessalegn Bosho D; Kumela Goro K; Zeleke Negera G
    Can Respir J; 2020; 2020():4312519. PubMed ID: 33082891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in the use of chloroquine and hydroxychloroquine for the treatment of COVID-19.
    Sun J; Chen Y; Fan X; Wang X; Han Q; Liu Z
    Postgrad Med; 2020 Sep; 132(7):604-613. PubMed ID: 32496926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre-COVID-19 reports.
    Goldman A; Bomze D; Dankner R; Hod H; Meirson T; Boursi B; Maor E
    Br J Clin Pharmacol; 2021 Mar; 87(3):1432-1442. PubMed ID: 32964535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The efficacy and safety of hydroxychloroquine (HCQ) in treatment of COVID19 -a systematic review and meta-analysis.
    Choudhuri AH; Duggal S; Ahuja B; Biswas PS
    Indian J Med Microbiol; 2021 Apr; 39(2):159-170. PubMed ID: 33781656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of lopinavir/ritonavir combination in COVID-19: A systematic review, meta-analysis, and meta-regression analysis.
    Bhattacharyya A; Kumar S; Sarma P; Kaur H; Prajapat M; Shekhar N; Bansal S; Avti P; Hazarika M; Sharma S; Mahendru D; Prakash A; Medhi B
    Indian J Pharmacol; 2020; 52(4):313-323. PubMed ID: 33078733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of azithromycin and hydroxychloroquine in patients hospitalized with COVID-19: Network meta-analysis of randomized controlled trials.
    Chi G; Memar Montazerin S; Lee JJ; Kazmi SHA; Shojaei F; Fitzgerald C; Gibson CM
    J Med Virol; 2021 Dec; 93(12):6737-6749. PubMed ID: 34370328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Torsade de pointes associated with chloroquine, hydroxychloroquine, and azithromycin: a retrospective analysis of individual case safety reports from VigiBase.
    Saint-Gerons DM; Tabarés-Seisdedos R
    Eur J Clin Pharmacol; 2021 Oct; 77(10):1513-1521. PubMed ID: 33938974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mortality, viral clearance, and other clinical outcomes of hydroxychloroquine in COVID-19 patients: A systematic review and meta-analysis of randomized controlled trials.
    Kashour Z; Kashour T; Gerberi D; Tleyjeh IM
    Clin Transl Sci; 2021 May; 14(3):1101-1112. PubMed ID: 33606894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of chloroquine or hydroxychloroquine treatment on non-SARS-CoV2 viral infections: A systematic review of clinical studies.
    Cui X; Sun J; Minkove SJ; Li Y; Cooper D; Couse Z; Eichacker PQ; Torabi-Parizi P
    Rev Med Virol; 2021 Nov; 31(6):e2228. PubMed ID: 33694220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydroxychloroquine/chloroquine in patients with COVID-19 in Wuhan, China: a retrospective cohort study.
    Chen Z; Liu A; Cheng Y; Wang X; Xu X; Huang J; Ma Y; Gao M; Huang C
    BMC Infect Dis; 2021 Aug; 21(1):805. PubMed ID: 34384388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Role of Hydroxychloroquine in COVID-19: A Systematic Review and Meta-Analysis.
    Shamshirian A; Hessami A; Heydari K; Navaei RA; Ebrahimzadeh MA; Yip GW; Ghasemian R; Sedaghat M; Baradaran H; Yazdi SM; Aboufazeli E; Jafarpour H; Dadgostar E; Tirandazi B; Sadeghnezhad R; Karimifar K; Eftekhari A; Shamshirian D
    Ann Acad Med Singap; 2020 Oct; 49(10):789-800. PubMed ID: 33283842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Hydroxychloroquine/Chloroquine in COVID-19 Therapy: Two Sides of the Coin.
    Fatima U; Rizvi SSA; Fatima S; Hassan MI
    J Interferon Cytokine Res; 2020 Oct; 40(10):469-471. PubMed ID: 32881593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systematic review and meta-analysis of the effectiveness and safety of hydroxychloroquine in treating COVID-19 patients.
    Yang TH; Chou CY; Yang YF; Chien CS; Yarmishyn AA; Yang TY; Liu CH; Chang KJ; Yang YP; Chang YL
    J Chin Med Assoc; 2021 Feb; 84(2):233-241. PubMed ID: 32947506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chloroquine and hydroxychloroquine are associated with reduced cardiovascular risk: a systematic review and meta-analysis.
    Liu D; Li X; Zhang Y; Kwong JS; Li L; Zhang Y; Xu C; Li Q; Sun X; Tian H; Li S
    Drug Des Devel Ther; 2018; 12():1685-1695. PubMed ID: 29928112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.